antiflammin p1 has been researched along with dinoprostone in 2 studies
| Studies (antiflammin p1) | Trials (antiflammin p1) | Recent Studies (post-2010) (antiflammin p1) | Studies (dinoprostone) | Trials (dinoprostone) | Recent Studies (post-2010) (dinoprostone) |
|---|---|---|---|---|---|
| 23 | 0 | 3 | 29,105 | 1,346 | 6,357 |
| Protein | Taxonomy | antiflammin p1 (IC50) | dinoprostone (IC50) |
|---|---|---|---|
| Prostaglandin E2 receptor EP1 subtype | Homo sapiens (human) | 0.0155 | |
| Prostaglandin E2 receptor EP4 subtype | Homo sapiens (human) | 0.0031 | |
| Prostaglandin E2 receptor EP4 subtype | Rattus norvegicus (Norway rat) | 0.0021 | |
| Prostaglandin E2 receptor EP3 subtype | Homo sapiens (human) | 0.002 | |
| Prostaglandin E2 receptor EP2 subtype | Homo sapiens (human) | 0.0087 | |
| Prostacyclin receptor | Homo sapiens (human) | 0.26 | |
| Prostaglandin E2 receptor EP2 subtype | Rattus norvegicus (Norway rat) | 0.0052 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Märki, F; Pfeilschifter, J; Rink, H; Wiesenberg, I | 1 |
| Buttery, M; Cormier, M; Daddona, P; Leung, I; Mize, NK; Ruis, N | 1 |
2 other study(ies) available for antiflammin p1 and dinoprostone
| Article | Year |
|---|---|
'Antiflammins': two nonapeptide fragments of uteroglobin and lipocortin I have no phospholipase A2-inhibitory and anti-inflammatory activity.
Topics: Amino Acid Sequence; Animals; Annexins; Anti-Inflammatory Agents, Non-Steroidal; Calcium-Binding Proteins; Cells, Cultured; Dinoprostone; Glycoproteins; Macrophages; Mice; Molecular Sequence Data; Oligopeptides; Pancreas; Peptide Fragments; Phospholipases; Phospholipases A; Phospholipases A2; SRS-A; Swine; Uteroglobin | 1990 |
Antiflammin 1 peptide delivered non-invasively by iontophoresis reduces irritant-induced inflammation in vivo.
Topics: Administration, Cutaneous; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chlorpromazine; Dermatitis, Irritant; Dinoprostone; Disease Models, Animal; Erythema; Guinea Pigs; Iontophoresis; Peptide Fragments; Skin; Time Factors; Uteroglobin | 1997 |